1715 West 38th Street
Chattem Consumer Products' mission is the satisfaction of consumer needs in personal and health care areas through the marketing of brand name products which are of excellent quality and proven efficacy. These products are promoted through the national media and are distributed through the mass distribution channels of food, drug and general merchandisers. The objective is to create or maintain a leadership position in each of our domestic markets and to thereby provide superior earnings while also building the value of each brand.
Chattem, Inc. manufactures and markets a diverse array of brand name pharmaceuticals, toiletries, and cosmetic items. Focusing on smaller product lines that it can market without competing directly against other giant companies in the business, Chattem has had a successful history in helping such products flourish. Over the years, it has manufactured and promoted over-the-counter drugs such as Pamprin, Premsyn PMS, and Norwich Aspirin; analgesics such as Flex-all 454, Icy Hot, and Benzodent; toiletries such as Sun-In Hair Lightener, Ultraswim Shampoo, Bullfrog Sunblock, MUDD Facial Masque, and pHisoderm; and the Corn Silk, Quenchers, and Baby Soft cosmetics lines. Chattem distributes its products across the United States, Canada, Europe, and throughout numerous other international markets.
The Early Years
Chattem's beginnings can be traced to the year 1879, when a small business called the Chattanooga Medicine Company was created to produce and sell Black-Draught, a senna-based laxative. The product had been invented almost half a decade earlier by a doctor who sold it from the back of a covered wagon through a small enterprise called the Dr. A.Q. Simmons Liver Medicine Company. Black-Draught had sold well in the southern United States until the Civil War, but struggled thereafter. It was then that Z.C. Patten purchased all rights to Black-Draught from Dr. Simmons's son-in-law and founded the Chattanooga Medicine Company to market the product.
With the help of four other Chattanooga businessmen, Patten began an aggressive marketing plan to boost sales of Black-Draught. He used letters of endorsement from satisfied customers to create a stronger trade base in the southern states and, in doing so, posted first year sales of $35,488. This success prompted Patten and his partners to expand their product line; therefore, a menstrual relief product for women called Dr. McElree's Wine of Cardui was introduced in 1880. To maintain the company's building reputation for quality, the new product was delivered to customers with the agreement that they would pay for it only if fully satisfied with its results. Wine of Cardui immediately became successful, as more than 6,500 women reported cures and sent payment to the company for an initial shipment of 7,000 bottles.
With both of its products becoming huge regional successes, the Chattanooga Medicine Company soon implemented a sales force to cover its expanding territories and combat the effects of the slow distribution characteristic of the horse and buggy era. This effort helped the company enter into new areas of the country, where consumers quickly accepted its products. According to the company's historical information, customers were so pleased with the new products that their subsequent communications to the company were massive, and the Chattanooga Medicine Company "quickly became the largest generator of mail in the Chattanooga area and was assigned its own government-paid post office on the premises." Using this resource, the company launched a massive print advertising campaign, which included the distribution of items such as flyers, wall calendars, almanacs, and even songbooks for churchgoers. The prevalence of these items ensured that the company's product names were constantly in the eyes of the public, a tactic that aided in the Chattanooga Medicine Company's rapid growth throughout its early years.
The Early 1900s: A New Era for the Chattanooga Medicine Company
In 1881, an Arkansas crop failure left many of the company's clients unable to pay for the products being shipped to them. Furthermore, two separate fires and a flood in the early 1890s left the company headquarters in near-ruins three different times. Although the company was doing well enough to expand in 1893 to include a branch office in St. Louis, Patten's business partners became uneasy and sold their shares in the company to his nephews, John A. Patten and Zeboim Carter Patten. The two brothers began running the business as partners in 1906, just five years after the Chattanooga Medicine Company had grown to include a second branch office in San Francisco. The company's sales throughout the country were booming, and in the following year Wine of Cardui surpassed the $1 million mark in annual sales.
Unfortunately, John A. Patten died unexpectedly in 1916 at the age of 48, leaving his brother to operate the business alone. Before his death, John A. Patten had not only played a key role in the company's successful use of billboard and print advertising, but had also engineered the company's entrance into the export business on an international scale. His efforts had introduced the company to a great deal of success and affluence, and his death was a huge blow to its continued growth potential. Although his brother did an excellent job in helping the company survive the effects of the Depression, the Chattanooga Medicine Company's growth was stagnant for many years. In 1938, Zeboim Carter Patten passed the modest operation on to his nephew, Lupton Patten, who at age 31 became the youngest president in the company's almost 60-year history.
Lupton Patten immediately began to modernize the company, adding new automated machinery and equipment to the packaging plants and branch offices. He also began using the services of numerous advertising and consulting firms, which resulted in both the creation of the company's own research program and its entrance into the specialty chemicals business. The company began developing specialized chemical products that it could sell to other manufacturers for use in their own consumer products, and this helped generate more annual earnings. The company also got a boost when it was called upon to produce foods and medicines for the U.S. Army during World War II. In addition to the manufacture of its own consumer products, the company actually produced more than 34 million packets of K-rations for U.S. troops. During this time, the company's newly formed research division was continually faced with the need to alter its own products when traditional ingredients became unavailable. The company achieved record earnings during those years nonetheless and was left in excellent financial condition at the conclusion of the war.
Post-World War II Restructuring and Expansion
After the war ended, the company was restructured to include two main operating divisions: the consumer products division and the specialty chemicals division. The consumer products division was responsible for the production and distribution of the company's many food and drug products, and the specialty chemicals division focused mainly on research and development and continued supplying chemical ingredients for other manufacturer's products as well as its own. For example, research and experimentation during the war years led to the creation of a liquid form of Black-Draught, as well as to different aluminum compounds that became important ingredients in other companies' antacids, such as Rolaids.
Then in 1958, in what seemed to be an emerging family and company trend, Lupton Patten also died unexpectedly at the early age of 51. The company's operations were left to his nephew, Alex Guerry, who spent the next decade altering the Chattanooga Medicine Company's financial structure to provide it with greater growth potential. After a decade had passed and the company had continued to prosper in the specialty chemicals realm, he realized that the company's name did not accurately reflect the businesses with which it was involved at that point in time. Therefore, Guerry called for a corporate name change in 1968, and the company became the Chattem Drug and Chemical Company. The following year, Chattem sold its stock in a public offering, which was the first time that the company's stock had been openly available to outsiders.
Guerry then led the company in acquiring several other small businesses, whose products soon supplemented Chattem's own. The first major acquisition was the DePree Company of Michigan, a health and beauty care business that was a successful addition to the consumer products division. That purchase was followed by the addition of the Petrochemicals Company of Texas to Chattem's specialty chemicals division. Meanwhile, Chattem continued to create and market its own successful products. Pamprin, a women's menstrual pain relief medicine, had been introduced in 1962 to take the place of Wine of Cardui, and by 1970 was one of Chattem's leading products.
It was in the mid-1970s that Chattem made a move that became characteristic of its business procedure for many years to come. It began purchasing the rights to small or struggling product lines from other companies, with the intent to help the products flourish by marketing them in small product niches where there would be little competition from the other giant companies in the industry. Within a five-year time period, Chattem acquired Sun-In Hair Lightener, MUDD Facial Masque, and the Corn Silk cosmetics line. The adoption of these products marked Chattem's entrance into the cosmetics and toiletries business, once again rendering the company name an incomplete representation of its business ventures. Therefore, in 1979 the company became Chattem, Inc., a designation that more aptly reflected its rapidly expanding scope of business.
Acquisitions Throughout the 1980s
Chattem's newly acquired products responded positively to the increased advertising and distribution that they received from their new owner, and sales began to rise almost immediately. Therefore, Chattem continued the acquisition trend with the 1980 purchase of Love's Fragrances, a perfume line targeted at teenagers, and the 1983 purchase of Quencher cosmetics. Along with the addition of a liquid form of makeup to the Corn Silk product line, Chattem hoped to round out its cosmetics offerings with the new purchases. Unfortunately, although both products performed adequately for Chattem, neither one possessed the growth potential the company was seeking. As a result, both product lines were sold to outside suitors by 1985. The company also divested its original acquisitions, DePree and Petrochemicals. The consumer products division was still expanding steadily, however, and for the first time ever it began to surpass the specialty chemicals division in annual profits.
The success of Chattem's consumer products division was further bolstered by the 1985 acquisition of Nullo Deodorant tablets and the 1986 acquisitions of Bullfrog waterproof sunblock and Ultraswim chlorine removal shampoo. As with most of its other successful products, these items demanded only small amounts of retail shelf space, due to the fact that they were single products that did not have large line extensions. This helped Chattem convince many stores with limited shelf space to carry its products and made it possible for the company to market the majority of its products nationwide. On the rare occasions when Chattem did extend one of its product lines, it was done to gain a stronger customer base by tailoring the product to the demands of the consumers. For example, in 1988 Chattem added two new variations of its Sun-In Hair Lightener product to store shelves when it unveiled "Gentle Highlights" and "Natural Lemon" Sun-In. The gentle variety was targeted at younger first-time users, and "Natural Lemon" was a means of capturing reluctant clientele.
The year 1989 saw Chattem achieve one of its largest acquisitions with the purchase of Flex-all 454 topical analgesic. At the time of the purchase, Flex-all 454 averaged less than $1 million in annual sales. Chattem immediately launched an extensive $5 million advertising and distribution campaign (the company's largest ever), including television and print advertisements featuring football great Joe Namath. These efforts were incredibly successful, and within a year the product achieved more than $10 million in sales. These new profits were supplemented by the retail sales of another 1989 acquisition, Norwich Aspirin, and together the new products helped Chattem achieve a whopping 27.3 percent return on equity in 1990.
The 1990s and Beyond
After guiding Chattem through some of its most defining years, Alex Guerry died in 1990 and left control of the company to his son, Zan Guerry. Noting the positive results that years of successful product acquisitions had produced, Guerry immediately began negotiating a deal to purchase Icy Hot brand topical analgesic from Procter & Gamble. The transaction was finalized by mid-1991, at which point Chattem had become known as a "guerrilla marketer," defined in a 1991 edition of The Insiders' Chronicle as "the ability to 'pick a niche and dominate it."' The purchase of Icy Hot increased Chattem's share of the market for topical analgesics used to relieve sore muscles to 16 percent.
Meanwhile, Chattem was successfully dominating other product niches as well. Sales of Pamprin had combined with sales of a more recent product, Premsyn PMS, to help Chattem control more than 40 percent of the menstrual symptom relief market. Similarly, the company's Corn Silk cosmetics line was a leader in the oil-absorbent makeup category. When purchased by Chattem, all of these products had been struggling to reach the million dollar mark in sales each year. Years of boosted marketing support, however, had enabled each of them to contribute multimillion dollar sales figures to the company's earnings by the early 1990s.
In 1991 Chattem's specialty chemicals division enjoyed a 45 percent increase in sales, even though the United States' chemical process industries in general experienced decreases. The increase was attributed by some to the fact that Chattem's specialty chemicals division was a leading producer and patent holder of different aluminum compounds that were necessary in the production of many other companies' products. The success of its specialty chemicals division helped Chattem achieve its first $100 million sales year in history and prompted the company to expand itself even further by opening a 1.3 million-share secondary offering of its stock to the public in 1992.
It was not until 1994 that Chattem made another notable acquisition, when it added two new products to its consumer products division: pHisoderm facial cleanser and Benzodent oral analgesic. Chattem's continued emphasis on consumer products expansion then prompted an even more notable 1994 event, as the company decided to put its specialty chemicals division up for sale. The decision was a reflection of the company's desire to focus solely on its consumer products division, which at that point accounted for almost 90 percent of Chattem's yearly income. The specialty chemicals division was purchased by the privately held Elcat Company of New Jersey for $25 million, and the sale was finalized by mid-1995. Elcat then maintained both the division's operations and its name of Chattem Chemicals. Without its specialty chemicals division, Chattem continued its consumer products acquisition process with the purchase of rights to Gold Bond Medicated Powder in early 1996.
After growing from a covered wagon peddler of laxative in the 1800s to a multimillion dollar conglomerate whose products were being distributed worldwide, Chattem entered the late 1990s with the desire and potential to expand further its product offerings and distribution territory. By 1996, Chattem was producing and marketing name-brand products such as Pamprin, Premsyn PMS, Norwich Aspirin, Sun-In, Ultraswim Shampoo and Conditioner, Bullfrog Sunblock, Flex-all 454, Icy Hot, Benzodent, pHisoderm, MUDD Facial Masque, Corn Silk, and Gold Bond Medicated Powder. With a continually increasing list of successful product offerings, and with sales divisions already operating in the United States, Canada, and Europe, Chattem seemed to possess the resources to achieve its goals.
Principal Subsidiaries: Chattem Consumer Products; Chattem International; Chattem (U.K.) Limited; Chattem (Canada) Inc.; HBA Insurance Limited; Signal Investment & Management Co.
Comment about this article, ask questions, or add new information about this topic: